The global medical foods market size surpassed USD 23.59 billion in 2023 and is anticipated to be worth around USD 38.90 billion by 2033, growing at a CAGR of 5.13% from 2024 to 2033.
Key Points
- The North America medical foods market size accounted for USD 7.75 billion in 2023 and is expected to rise around USD 12.45 billion by 2033.
- North America led the global market with a major market share of 32% in 2023.
- Asia Pacific will be the fastest-growing region in the global market during the projected period.
- By route of administration, the oral segment has generated more than 71% of market share in 2023.
- By route of administration, the enteral segment is expected to witness the fastest growth over the forecast years.
- By product type, the powder segment accounted for the largest market share in 2023.
- By product type, the liquid segment is anticipated to grow at the fastest rate during the forecast period.
- By application, the cancer segment has held the largest market share in 2023.
- By sales channels, the institutional sales channel segment has captured more By sales channels, the online sales segment will be the fastest-growing segment during the forecast period.
The global medical foods market is experiencing significant growth driven by increasing awareness about nutritional therapy and personalized healthcare. Medical foods are specially formulated and intended for the dietary management of specific diseases or conditions under medical supervision. This market encompasses a diverse range of products tailored to address nutritional deficiencies associated with various medical conditions, offering targeted nutritional solutions beyond conventional foods or dietary supplements.
Get a Sample: https://www.precedenceresearch.com/sample/4244
Growth Factors
Several factors contribute to the growth of the medical foods market. Rising prevalence of chronic diseases such as diabetes, cancer, and cardiovascular disorders is driving demand for therapeutic nutritional products. Moreover, advancements in medical research and understanding of disease-specific nutritional needs are facilitating the development of innovative medical food formulations. Additionally, the emphasis on preventive healthcare and the integration of nutrition into disease management protocols are expanding the market opportunities for medical foods globally.
Region Insights
The market for medical foods exhibits regional variations influenced by healthcare infrastructure, regulatory frameworks, and disease prevalence. Developed regions like North America and Europe lead in market share due to established healthcare systems and high awareness about disease management through nutrition. In contrast, emerging economies in Asia-Pacific and Latin America are witnessing rapid market growth driven by increasing healthcare expenditures and a growing population affected by chronic diseases.
Medical Foods Market Scope
| Report Coverage | Details |
| Growth Rate from 2024 to 2033 | CAGR of 5.13% |
| Global Market Size in 2023 | USD 23.59 Billion |
| Global Market Size in 2024 | USD 24.80 Billion |
| Global Market Size by 2033 | USD 38.90 Billion |
| Largest Market | North America |
| Base Year | 2023 |
| Forecast Period | 2024 to 2033 |
| Segments Covered | By Route of Administration, By Product, By Application, and By Sales Channel |
| Regions Covered | North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa |
Medical Foods Market Dynamics
Drivers
Key drivers of the medical foods market include the growing aging population worldwide, which is more susceptible to age-related diseases necessitating specialized nutrition. Additionally, the rise in lifestyle-related disorders due to sedentary lifestyles and poor dietary habits is fueling demand for nutritional interventions. Furthermore, the shift towards personalized nutrition and the integration of medical foods into disease management protocols by healthcare professionals are contributing to market expansion.
Opportunities
The medical foods market presents numerous opportunities for manufacturers and healthcare providers. Collaborations between food technologists, healthcare professionals, and researchers can lead to the development of novel medical food formulations tailored for specific patient populations. Expanding distribution networks and strengthening partnerships with healthcare institutions can enhance market penetration. Furthermore, addressing unmet needs in disease-specific nutritional therapy presents untapped growth opportunities in niche segments.
Challenges
Despite growth prospects, the medical foods market faces challenges such as stringent regulatory requirements for product approval and labeling. Market fragmentation and lack of standardized definitions for medical foods in different regions can pose barriers to market entry. Moreover, limited reimbursement policies for medical foods under healthcare systems in some countries hinder widespread adoption and affordability, impacting market growth potential.
Read Also: Infertility Drugs Market Size to Surpass USD 6.73 Bn By 2033
Medical Foods Market Recent Developments
- In July 2022, Nestle launched the first Food for Medical Purpose (FSMP) for cancer patients suffering from tumor conditions. The product was called Oral Impact Su Yi Su. It took five years to approve this product. It contains arginine, fish oil omega-3, and nucleotide on top of other ingredients. The product was designed to address the problem of inflammation and compromised immunity.
Medical Foods Market Companies
- Danone
- Nestlé
- Abbott
- Targeted Medical Pharma Inc.
- Primus Pharmaceuticals Inc.
- Fresenius Kabi AG
- Mead Johnson & Company, LLC
Segments Covered in the Report
By Route of Administration
- Oral
- Enteral
By Product
- Powder
- Pills
- Liquid
- Other
By Application
- Chronic Kidney Disease
- Minimal Hepatic Encephalopathy
- Chemotherapy-induced Diarrhoea
- Pathogen-related Infections
- Diabetic Neuropathy
- Adhd
- Depression
- Alzheimer’s Disease
- Nutritional Deficiency
- Orphan Diseases
- Tyrosinemia
- Eosinophilic esophagitis
- Fpies
- Phenylketonuria
- Msud
- Homocystinuria
- Others
- Wound Healing
- Chronic Diarrhea
- Constipation Relief
- Protein Booster
- Dysphagia
- Pain Management
- Parkinson’s Disease
- Epilepsy
- Other cancer-related Treatments
- Severe protein Allergy
- Cancer
- Cachexia
- Other
By Sales Channel
- Online Sales
- Retail Sales
- Institutional Sales
By Geography
- North America
- Asia Pacific
- Europe
- Latin America
- Middle East & Africa
Contact Us:
Mr. Alex
Sales Manager
Call: +1 9197 992 333
Email: sales@precedenceresearch.com
Web: https://www.precedenceresearch.com
Blog: https://www.expresswebwire.com/
Blog: https://www.uswebwire.com/
